Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastián Rivera-Orellana

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|April 29, 2025
Global analysis of actionable genomic alterations in thyroid cancer and precision-based pharmacogenomic strategiesSamantha Espinoza-Ferrao, Gabriela Echeverría-Garcés, Sebastián Rivera-Orellana, et al.
Frontiers in Cell and Developmental Biology|September 15, 2025
Reprogramming cancer immunity with next-generation combination therapiesNikolaos C Kyriakidis, Carolina E Echeverría, Jhommara Bautista, et al.
Frontiers in Pharmacology|May 17, 2024
Gastric cancer actionable genomic alterations across diverse populations worldwide and pharmacogenomics strategies based on precision oncologyGabriela Echeverría-Garcés, María José Ramos-Medina, Rodrigo Vargas, et al.
Clinical and Experimental Medicine|July 20, 2025
Oncolytic virotherapy and tumor microenvironment modulationSebastián Rivera-Orellana, Jhommara Bautista, David Palacios-Zavala, et al.
Frontiers in Pharmacology|May 9, 2024
The pharmacoepigenetic paradigm in cancer treatmentBelén Ocaña-Paredes, Sebastián Rivera-Orellana, David Ramírez-Sánchez, et al.
Heliyon|September 19, 2024
Worldwide analysis of actionable genomic alterations in lung cancer and targeted pharmacogenomic strategiesGabriela Echeverría-Garcés, María José Ramos-Medina, Ariana González, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|April 29, 2025
Global analysis of actionable genomic alterations in thyroid cancer and precision-based pharmacogenomic strategiesSamantha Espinoza-Ferrao, Gabriela Echeverría-Garcés, Sebastián Rivera-Orellana, et al.
Frontiers in Cell and Developmental Biology|September 15, 2025
Reprogramming cancer immunity with next-generation combination therapiesNikolaos C Kyriakidis, Carolina E Echeverría, Jhommara Bautista, et al.
Frontiers in Pharmacology|May 17, 2024
Gastric cancer actionable genomic alterations across diverse populations worldwide and pharmacogenomics strategies based on precision oncologyGabriela Echeverría-Garcés, María José Ramos-Medina, Rodrigo Vargas, et al.
Clinical and Experimental Medicine|July 20, 2025
Oncolytic virotherapy and tumor microenvironment modulationSebastián Rivera-Orellana, Jhommara Bautista, David Palacios-Zavala, et al.
Frontiers in Pharmacology|May 9, 2024
The pharmacoepigenetic paradigm in cancer treatmentBelén Ocaña-Paredes, Sebastián Rivera-Orellana, David Ramírez-Sánchez, et al.
Heliyon|September 19, 2024
Worldwide analysis of actionable genomic alterations in lung cancer and targeted pharmacogenomic strategiesGabriela Echeverría-Garcés, María José Ramos-Medina, Ariana González, et al.
Pageof 1